Bill > HB07179

This bill introduces several changes related to pharmaceutical marketing and drug distribution in Connecticut. First, it modifies regulations for pharmaceutical marketing firms, requiring them to annually register with the Department of Consumer Protection, pay a registration fee, and provide a list of pharmaceutical representatives. The bill mandates that these firms report details about their representatives' interactions with healthcare professionals, including the number of contacts, specialties, and any samples or gifts provided. The department will then compile and publish an annual report on these activities. Second, the bill allows veterinarians to authorize certain personnel to dispense prescription veterinary drugs under specific conditions, such as maintaining proper medical records and establishing a veterinarian-client-patient relationship. Third, the bill updates regulations for selling non-legend drugs in vending machines, establishing detailed requirements for machine maintenance, labeling, and content. Lastly, the bill expands provisions for distributing opioid antagonists through secure boxes and vending machines, aiming to increase access to overdose prevention resources while maintaining safety and regulatory oversight. These changes are designed to enhance transparency, safety, and accessibility in pharmaceutical and drug distribution practices.

Justice

General Law Committee (J)

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB07179&which_year=2025